Intas $767m dual currency deal enters senior

A dual currency acquisition financing for Indian company Intas Pharmaceuticals’ purchase of a portfolio of assets in the UK and Ireland, was launched into senior syndication last week. The trade offers banks two titles, including that of mandated lead arranger and bookrunner.